Literature DB >> 15282106

Discovery stage pharmacokinetics using dried blood spots.

Patrick Beaudette1, Kevin P Bateman.   

Abstract

Early in the discovery stage, the measurement of drug candidates in biological fluids as a function time provides important information used in decision making for lead optimization. The detection methodology primarily used is liquid chromatography coupled to triple quadrupole mass spectrometry (LC-MS). Sample preparation is an important aspect of these experiments and robotic-based automation is commonly used. The often overlooked aspect of these experiments is the sample collection itself. Typically, several hundred microliters of whole blood is collected and the plasma fraction separated for each time-point. The plasma is then transferred to an appropriate vessel for subsequent aliquoting and processing. We describe a method for performing discovery stage pharmacokinetic analysis using whole blood dried onto filter paper. The use of dried blood spots is a well established technique for neo-natal screening, and its application to early screening of drug candidates proves to be robust, reliable and reproducible.

Mesh:

Substances:

Year:  2004        PMID: 15282106     DOI: 10.1016/j.jchromb.2004.06.018

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  12 in total

1.  Use of dried blood spots in drug development: pharmacokinetic considerations.

Authors:  Malcolm Rowland; Gary T Emmons
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

2.  Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.

Authors:  Enaksha R Wickremsinhe; Everett J Perkins
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

3.  Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group.

Authors:  Christopher Evans; Mark Arnold; Peter Bryan; Jeffrey Duggan; Christopher A James; Wenkui Li; Steve Lowes; Luca Matassa; Timothy Olah; Philip Timmerman; Xiaomin Wang; Enaksha Wickremsinhe; John Williams; Eric Woolf; Patricia Zane
Journal:  AAPS J       Date:  2014-12-09       Impact factor: 4.009

4.  Validation of a ligand binding assay using dried blood spot sampling.

Authors:  Daniel Burns; Laura Brunner; Surendran Rajendran; Beth Johnson; Mark Ma; Jin Wang
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

5.  Using miniature MS system with automatic blood sampler for preclinical pharmacokinetics study.

Authors:  Fan Pu; Wenpeng Zhang; Kevin P Bateman; Yong Liu; Roy Helmy; Zheng Ouyang
Journal:  Bioanalysis       Date:  2017-11-02       Impact factor: 2.681

6.  Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis.

Authors:  Teresa L Parsons; Mark A Marzinke; Thuy Hoang; Erin Bliven-Sizemore; Marc Weiner; William R Mac Kenzie; Susan E Dorman; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

7.  Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.

Authors:  Parul Patel; Hussain Mulla; Venkatesh Kairamkonda; Neil Spooner; Sonya Gade; Oscar Della Pasqua; David J Field; Hitesh C Pandya
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

8.  Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry.

Authors:  Dennis R Koop; Lisa A Bleyle; Myrna Munar; Ganesh Cherala; Amira Al-Uzri
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-03-04       Impact factor: 3.205

9.  Rapid DNA extraction from dried blood spots on filter paper: potential applications in biobanking.

Authors:  Eun-Hye Choi; Sang Kwang Lee; Chunhwa Ihm; Young-Hak Sohn
Journal:  Osong Public Health Res Perspect       Date:  2014-11-01

10.  Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.

Authors:  Virginie Ancrenaz; Julien Déglon; Caroline Samer; Christian Staub; Pierre Dayer; Youssef Daali; Jules Desmeules
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-10-05       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.